Publications by authors named "Lisa Mahnke"

Claim this Profile
C
Correction to: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma.
Murtuza Bharmal, Fatoumata Fofana, Carla Dias Barbosa, Paul Williams, Lisa Mahnke

Health Qual Life Outcomes· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble Hetero-Polyoxovanadates and Their Solution Chemistry Analyzed by Electrospray Ionization Mass Spectrometry.
Ulrike Warzok, Lisa K Mahnke, Wolfgang Bensch

Chemistry· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences.
Howard L Kaufman, Carla Dias Barbosa, Isabelle Guillemin, Jérémy Lambert, Lisa Mahnke

Patient· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Water-Soluble Cluster Compound {Zn(en) } [V Sb O (H O)]⋅ (Ethylenediamine) ⋅10 H O as a Synthon for the Generation of Two New Antimonato Polyoxovanadates.
Lisa K Mahnke, Ulrike Warzok, Mengxi Lin, Christian Näther, Christoph A Schalley

Chemistry· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors.
Julius Strauss, Christopher R Heery, Jeffrey Schlom, Ravi A Madan, Liang Cao, Lisa Mahnke

Clin Cancer Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Configurational Isomerism in Polyoxovanadates.
Lisa K Mahnke, Aleksandar Kondinski, Ulrike Warzok, Christian Näther, Jan van Leusen

Angew Chem Int Ed Engl· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma.
Murtuza Bharmal, Fatoumata Fofana, Carla Dias Barbosa, Paul Williams, Lisa Mahnke

Health Qual Life Outcomes· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe.
Jürgen C Becker, Eva Lorenz, Selma Ugurel, Thomas K Eigentler, Felix Kiecker, Lisa Mahnke

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA.
C Lance Cowey, Lisa Mahnke, Janet Espirito, Christoph Helwig, Dina Oksen

Future Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma.
Dirk Schadendorf, Paul Nghiem, Shailender Bhatia, Axel Hauschild, Philippe Saiag, Lisa Mahnke

Oncoimmunology· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.
Paul Nghiem, Howard L Kaufman, Murtuza Bharmal, Lisa Mahnke, Hemant Phatak

Future Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Howard L Kaufman, Jeffery Russell, Omid Hamid, Shailender Bhatia, Patrick Terheyden, Lisa Mahnke

Lancet Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein.
Sarah M Robertson, Xia Luo, Neeraj Dubey, Chonghua Li, Ajit B Chavan, Lisa Mahnke

J Clin Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.
Mark S Sulkowski, Kenneth E Sherman, Douglas T Dieterich, Mohammad Bsharat, Lisa Mahnke

Ann Intern Med· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.
Xiaodong Wang, Marta Boffito, Jenny Zhang, Ellen Chung, Li Zhu, Lisa Mahnke

AIDS Patient Care STDS· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
Jenny Zhang, Ellen Chung, Cynthia Yones, Anna Persson, Lisa Mahnke

Antivir Ther· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects.
Li Zhu, Anna Persson, Lisa Mahnke, Timothy Eley, Tong Li

J Clin Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic changes in HIV-infected, drug experienced patients treated with atazanavir.
Lisa Mahnke, Michael Child, Lawrence Satin, Anna Persson, Richard Bertz

AIDS· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation.
Lisa Mahnke, David Clifford

AIDS Res Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of HIV-2 Vpx by modeling and insertional mutagenesis.
Lisa A Mahnke, Michael Belshan, Lee Ratner

Virology· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conserved amino acids of the human immunodeficiency virus type 2 Vpx nuclear localization signal are critical for nuclear targeting of the viral preintegration complex in non-dividing cells.
Michael Belshan, Lisa A Mahnke, Lee Ratner

Virology· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photo quiz. Chronic foot ulcers in a patient with hepatitis C.
Lisa Mahnke, Richard Groger

Clin Infect Dis· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis